Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Subscribe
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
GSK
Biotech
GSK initiates breakup with Ideaya, hands back 2 programs
GSK is walking away from Ideaya after a five-year-long partnership that initially covered three of Ideaya's synthetic lethality programs.
Zoey Becker
Dec 9, 2025 7:15am
Fierce Pharma
GSK's Tesaro, AnaptysBio lock horns over Jemperli agreement
Nov 21, 2025 9:46am
GSK picks 1st biotech partners under $7B Flagship pact
Nov 20, 2025 6:30am
GSK pens $50M pact to join Big Pharma peers in emerging modality
Nov 19, 2025 4:40am
FDA reveals 2nd round of 'national priority' voucher winners
Nov 6, 2025 3:12pm
GSK loses hope for CD226 cancer therapies, dropping ph. 2 assets
Oct 29, 2025 6:29am
